| Field | Specification |
|---|---|
| Target | |
| Alternative names | Glyceraldehyde-3-phosphate dehydrogenase;GAPDH;1.2.1.12;Peptidyl-cysteine S-nitrosylase GAPDH;2.6.99.-;GAPDH;GAPD;CDABP0047, OK/SW-cl.12; |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthesized peptide derived from human GAPDH Mouse Monoclonal |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Liquid |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Clone 17G14 is a mouse monoclonal antibody that recognizes glyceraldehyde-3-phosphate dehydrogenase (gene GAPDH) in human, mouse and rat samples and is validated for Western blot, IHC, ICC/IF, immunoprecipitation and flow cytometry. The predicted molecular weight is 36.1 kDa, and the supplier reports an observed band at about 36 kDa.
GAPDH catalyzes a central step of glycolysis, the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate. Because it is abundant and broadly expressed, it is one of the most widely used loading controls for Western blot, although it also has non-glycolytic roles in the nucleus, in membrane trafficking and in translational control.
| Target | Glyceraldehyde-3-phosphate dehydrogenase (gene GAPDH; UniProt P04406, human) |
|---|---|
| Clone | 17G14 |
| Host / Clonality / Isotype | Mouse / Monoclonal / IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Liquid |
| Formulation | PBS (pH 7.4); 150 mM NaCl; 0.02% sodium azide; 50% glycerol; plus stabilizers |
| Calculated MW | 36.1 kDa |
| Observed MW | 36 kDa |
| Storage | Long term: −20 °C for up to 12 months. Frequent use: 4 °C for up to 1 month. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 1:1000–1:5000 |
|---|---|
| Immunohistochemistry | 1:50–1:200 |
| Immunocytochemistry / Immunofluorescence | 1:50–1:200 |
| Immunoprecipitation | 1:50 |
| Flow cytometry | 1:50 |
Samples with a confirmed band (WB): human HeLa cells, human Jurkat cells, human THP-1 cells, human A549 cells, rat kidney tissue, rat brain tissue, mouse kidney tissue, mouse brain tissue.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 10% SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 1:1000 overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human colon cancer tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Samples with confirmed staining (ICC/IF): HeLa cells.
Immunogen
Synthetic peptide based on the sequence of human GAPDH Mouse Monoclonal.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. UniProt places glyceraldehyde-3-phosphate dehydrogenase in the cytoplasm, nucleus and membrane. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Xingyu Zhou et al. (2025) Microneedle delivery of CAR-M-like engineered macrophages alleviates intervertebral disc degeneration through enhanced efferocytosis capacity. Cell Reports Medicine. 10.1016/j.xcrm.2025.102079
Zhuangzhuang Chen et al. (2023) Low ambient temperature exposure increases the risk of ischemic stroke by promoting platelet activation. Science of the Total Environment. 10.1016/j.scitotenv.2023.169235
Zhou Xuexia et al. (2022) Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis. Cell Death & Disease. 10.1038/s41419-022-05265-y
Chen Jia et al. (2022) Decoy receptor 2 mediates the apoptosis-resistant phenotype of senescent renal tubular cells and accelerates renal fibrosis in diabetic nephropathy. Cell Death & Disease. 10.1038/s41419-022-04972-w
Chen Jia et al. (2020) Decoy receptor 2 mediation of the senescent phenotype of tubular cells by interacting with peroxiredoxin 1 presents a novel mechanism of renal fibrosis in diabetic nephropathy. Kidney International. 10.1016/j.kint.2020.03.026
Du Wei-hong et al. (2026) TNF-α/PAD4 axis drives hyperhomocysteine-induced white matter injury after acute ischemic stroke. ACTA Pharmacologica Sinica. 10.1038/s41401-026-01795-9
Jiangping Wu et al. (2026) A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis. Phytomedicine. 10.1016/j.phymed.2026.158123
Xiaoyin Guo et al. (2024) Mechanism underlying the role of integrin α3β1 in adhesive dysfunction between thyroid cells induced by diesel engine exhaust particles. Science of the Total Environment. 10.1016/j.scitotenv.2024.174535
Ye Runyi et al. (2021) Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogenesis. 10.1038/s41389-021-00350-x
Sun Kai et al. (2023) Inhibition of TRADD ameliorates chondrocyte necroptosis and osteoarthritis by blocking RIPK1-TAK1 pathway and restoring autophagy. Cell Death Discovery. 10.1038/s41420-023-01406-0
